14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IONS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Ionis Pharmaceuticals stock price ended at $43.09 on Thursday, after gaining 0.186%.
(Updated on May 02, 2024)

Buy candidate since May 01, 2024 Gain 0.19% PDF

The Ionis Pharmaceuticals stock price gained 0.186% on the last trading day (Thursday, 2nd May 2024), rising from $43.01 to $43.09. During the last trading day the stock fluctuated 2.32% from a day low at $42.63 to a day high of $43.62. The price has risen in 6 of the last 10 days and is up by 5.59% over the past 2 weeks. Volume fell on the last day by -332 thousand shares and in total, 648 thousand shares were bought and sold for approximately $27.91 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.88% during the next 3 months and, with a 90% probability hold a price between $34.12 and $38.47 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IONS Signals & Forecast

Mostly positive signals in the chart today. The Ionis Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $42.18 and $42.45. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 5.92%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Ionis Pharmaceuticals stock

Ionis Pharmaceuticals finds support from accumulated volume at $42.83 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.99 between high and low, or 2.32%. For the last week the stock has had daily average volatility of 2.88%.

Our recommended stop-loss: $41.37 (-4.00%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (IONS) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Ionis Pharmaceuticals to open at $43.11, and during the day (based on 14 day Average True Range), to move between $41.96 and $44.22, which gives a possible trading interval of +/-$1.13 (+/-2.62%) up or down from last closing price. If Ionis Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 5.24% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $42.83 (0.60%) than the resistance at $43.53 (1.02%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Ionis Pharmaceuticals will release earnings BMO on Tuesday, May 07, 2024.The consensus among the analysts for the expected earnings (EPS) is -$1.06. We will update the financials statements for Ionis Pharmaceuticals, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 5.95% in the first trading day after earnings release.

Is Ionis Pharmaceuticals stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 2.610 Buy Candidate Unchanged

Predicted Opening Price for Ionis Pharmaceuticals of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$43.11 ( 0.0542%) $43.09

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IONS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 44.10 2.35 %
R2 43.73 1.47 %
R1 43.49 0.93 %
Current price: 43.09
Support S1 42.74 -0.82 %
S2 42.50 -1.37 %
S3 42.12 -2.24 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 45.28 5.08 %
R2 44.43 3.11 %
R1 43.53 1.02 %
Current price 43.09
Support S1 42.83 -0.603%
S2 42.18 -2.11%
S3 41.84 -2.90%

FAQ

What is the symbol for Ionis Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Ionis Pharmaceuticals is IONS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ionis Pharmaceuticals Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

How to buy Ionis Pharmaceuticals Stock?
Ionis Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ionis Pharmaceuticals Stock.

What's the current price of Ionis Pharmaceuticals Stock?
As of the end of day on the May 02, 2024, the price of an Ionis Pharmaceuticals (IONS) share was $43.09.

What is the 52-week high and low for Ionis Pharmaceuticals Stock?
The 52-week high for Ionis Pharmaceuticals Stock is $54.44 and the 52-week low is $34.32.

What is the market capitalization of Ionis Pharmaceuticals Stock?
As of the May 02, 2024, the market capitalization of Ionis Pharmaceuticals is 6.269B.

When is the next earnings date for Ionis Pharmaceuticals?
The upcoming earnings date for Ionis Pharmaceuticals is May 07, 2024.
Click to get the best stock tips daily for free!

About Ionis Pharmaceuticals

Ionis Pharmaceuticals Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various... IONS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT